Search

Stocks in Biotechnology Sector

3SBio
Abraxis Bioscience
Achillion Pharmaceuticals
Adeona Pharmaceuticals
ADVAXIS
AEterna Zentaris
Alnylam Pharmaceuticals
American Oriental Bioengineering
Amicus Therapeutics
Anadys Pharmaceuticals
Antigenics
Arca Biopharma
Athersys
BIO-MATRIX SCIENTIFI
BioDelivery Sciences International
BIOHEART, INC.
Biosante Pharmaceuticals
BioTime
Cadence Pharmaceuticals
CALECO PHARMA CORP.
Cardiovascular Systems
Cel-Sci
Cell Therapeutics
CELLCYTE GENETICS
CHAMPIONS BIOTECHNLG
Chelsea Therapeutics International
Clinical Data
CombinatoRx,
Corcept Therapeutics
Curis
Cypress Bioscience
Cytori Therapeutics
DARA Biosciences
Discovery Laboratories
Emergent Biosolutions
Eurand N.V.
Exelixis
GENTA
Genzyme
Gilead Sciences
Halozyme Therapeutics
HEALTH DISCOVERY CP
Heska
Idenix Pharmaceuticals
IGI Laboratories
ImmunoGen
Incyte
Inovio Biomedical
INTELLECT NEUROSCIEN
INTL STEM CELL
Lexicon Pharmaceuticals
Ligand Pharmaceuticals
MANHATTAN PHARMA
Martek Biosciences
MediciNova
Medivation
Micromet
Momenta Pharmaceuticals
Neuralstem
NEW ENERGY TECHNOLGS
NORTHWEST BIOTH NEW
NOVELOS THERAPEUTICS
NUTRA PHARMA
OMNI BIO PHARM
Oncothyreon Inc .
Opexa Therapeutics
ORAGENICS
Osiris Therapeutics
OXiGENE
Peregrine Pharmaceuticals
Pluristem Therapeutics
Poniard Pharmaceuticals
Protalix BioTherapeutics
PULMO BIOTECH
QLT
Regeneron Pharmaceuticals
Repros Therapeutics
RXi Pharmaceuticals
Savient Pharmaceuticals
Senesco Technologies
Sequenom
SOLIGENIX, INC.
Sunesis Pharmaceuticals
Targacept
Theravance
Tongjitang Chinese Medicines Company
TRANSDEL PHARMACTL
Trimeris
URIGEN PHARMACEUTCLS
Vical
VITRO DIAGNOSTICS
XENACARE HOLDINGS
XOMA
ZymoGenetics
Aastrom Biosciences
ACADIA Pharmaceuticals
Acorda Therapeutics
ADVANCED LIFE SCIENC
ADVENTRX Pharmaceuticals
Affymax
AMARILLO BIOSCIENCES
Amgen
Amylin Pharmaceuticals
Anika Therapeutics
APPLIED DNA SCIENCES
ARIAD Pharmaceuticals
BIO-BRIDGE SCIENCE
BioCryst Pharmaceuticals
Biogen Idec
BioMarin Pharmaceutical
BioSpecifics Technologies
BRIDGETECH HOLDINGS
CADUS
Cambrex
Cardium Therapeutics
Celgene
CELLCEUTIX
Cerus
Charles River Laboratories International
China Biologic Products
CombiMatrix
Compugen
Cornerstone Therapeutics
Cyclacel Pharmaceuticals
Cytokinetics,
CytRx
Dendreon
Dyax
Enzon Pharmaceuticals
EXACT Sciences
Genetic Technologies
GenVec
GEOVAX LABS
GTx
HANA BIOSCIENCES
Hemispherx BioPharma
Human Genome Sciences
Idera Pharmaceuticals
Illumina
IMMUNOSYN CORPORATIN
Inhibitex
Insmed
InterMune
Jazz Pharmaceuticals
Life Technologies
LPATH
MannKind
MDRNA
Medicis Pharmaceutical
MICROCHANNEL TECH CP
Molecular Insight Pharmaceuticals
Nabi Biopharmaceuticals
Neurocrine Biosciences
Nile Therapeutics
Novavax
NPS Pharmaceuticals
Obagi Medical Products
OMNIMMUNE HOLDINGS
ONYX Pharmaceuticals
Optimer Pharmaceuticals
Orthologic
OSTEOLOGIX
PDL BioPharma
PharmAthene
POLYMEDIX
Progenics Pharmaceuticals
PROTEO
Qiagen N.V.
Questcor Pharmaceuticals
Repligen
Rexahn Pharmaceuticals
Sangamo BioSciences
Seattle Genetics
SENETEK PLC ADR NEW
Sinovac Biotech
StemCells
Talecris Biotherapeutics Holdings
Techne
Threshold Pharmaceuticals
Transcept Pharmaceuticals
Transition Therapeutics
Trubion Pharmaceuticals,
Vanda Pharmaceuticals
ViroPharma
Vivus
XenoPort
ZIOPHARM Oncology

Biotechnology Upgrades

Date
Ticker
Analyst
Old Rating
New Rating
01/12/2011
Noble Financial
Sell
Hold
01/04/2011
BofA/Merrill Lynch
Underperform
Neutral
12/17/2010
Canaccord Genuity
Hold
Buy
12/17/2010
Leerink Swann
Market Perform
Outperform

Biotechnology Downgrades

Date
Ticker
Analyst
Old Rating
New Rating
01/28/2011
Morgan Joseph
Buy
Hold
01/20/2011
Rodman & Renshaw
Market Outperform
Market Perform
01/20/2011
JMP Securities
Market Outperform
Market Perform
01/19/2011
Exane BNP Paribas
Outperform
Neutral

Biotechnology New Coverages

Date
Ticker
Analyst
Rating
01/24/2011
Williams Capital
Hold
01/24/2011
Rodman & Renshaw
Market Outperform
01/18/2011
Leerink Swann
Outperform
01/07/2011
William Blair
Outperform

Biotechnology Earnings

Date
Company
Actual
Expected
02/09/2012
-0.45
-0.39
02/09/2012
-0.02
0.27
02/09/2012
-0.69
-0.71
02/09/2012
-0.33
-0.32

On This Date

December 30, 1999:
The Nasdaq closed above 4,000 for the first time less than two months after its first close above 3,000. It ended up 84% for the year overall.

Research Assistant

Expand How to use this tool

Stock tracker

Today's Hot Stocks

Recently Viewed

Research Another Stock
Send Us Feedback!